Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVKD Cadrenal Therapeutics, Inc.

交易中 12-30 11:02:49 EST

15.19

-0.96

-5.94%

最高16.09	最低14.90	成交量1.15万
今开15.79	昨收16.15	日振幅7.34%
总市值2,708万	流通市值1,849万	总股本178.25万
成交额17.81万	换手率0.94%	流通股本121.75万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVKD","market":"US","secType":"STK","nameCN":"Cadrenal Therapeutics, Inc.","latestPrice":15.19,"timestamp":1735574428087,"preClose":16.15,"halted":0,"volume":11463,"delay":0,"floatShares":1217500,"shares":1782500,"eps":-5.894961,"marketStatus":"交易中","change":-0.96,"latestTime":"12-30 11:02:49 EST","open":15.79,"high":16.0856,"low":14.9,"amount":178057.793769,"amplitude":0.073412,"askPrice":15.2,"askSize":100,"bidPrice":15.02,"bidSize":6,"shortable":3,"etf":0,"ttmEps":-5.894961,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1735592400000},"marketStatusCode":2,"adr":0,"listingDate":1674190800000,"exchange":"NASDAQ","adjPreClose":16.15,"preHourTrading":{"tag":"盘前","latestPrice":16.06,"preClose":16.15,"latestTime":"09:04 EST","volume":421,"amount":6273.24943,"timestamp":1735567493902},"postHourTrading":{"tag":"盘后","latestPrice":15.85,"preClose":16.15,"latestTime":"19:07 EST","volume":455,"amount":7178.24,"timestamp":1735344454798},"volumeRatio":0.545681},"requestUrl":"/m/hq/s/CVKD/tweets","defaultTab":"tweets","newsList":[{"id":"2494098381","title":"Cadrenal Therapeutics, Inc.盘中异动 大幅跳水5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494098381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494098381?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:26","pubTimestamp":1735313206,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时26分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅跳水5.23%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232647ab94fe80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232647ab94fe80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CVKD"],"gpt_icon":0},{"id":"2493439766","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493439766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493439766?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:38","pubTimestamp":1734964697,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时38分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速跳水5.19%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122322381795eadbbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122322381795eadbbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","CVKD","BK4139"],"gpt_icon":0},{"id":"2492441986","title":"Cadrenal Therapeutics, Inc.盘中异动 大幅拉升7.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492441986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492441986?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:32","pubTimestamp":1734705175,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时32分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅拉升7.67%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223255a1fe2497&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223255a1fe2497&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","BK4007","LENZ"],"gpt_icon":0},{"id":"2492994824","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492994824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492994824?lang=zh_cn&edition=full","pubTime":"2024-12-18 03:26","pubTimestamp":1734463595,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日03时26分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速上涨5.00%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218032635ab7fd227&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218032635ab7fd227&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","CVKD","BK4139"],"gpt_icon":0},{"id":"2491530092","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘股价大跌6.47%报10.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491530092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491530092?lang=zh_cn&edition=full","pubTime":"2024-12-14 04:18","pubTimestamp":1734121118,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日04时18分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速下挫6.47%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121404183895e986ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121404183895e986ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CVKD","BK4007"],"gpt_icon":0},{"id":"2491593353","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491593353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491593353?lang=zh_cn&edition=full","pubTime":"2024-12-13 04:02","pubTimestamp":1734033742,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日04时02分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅跳水5.34%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.44%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213040222984ba1ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213040222984ba1ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CVKD","BK4139","LENZ"],"gpt_icon":0},{"id":"2490441860","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490441860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490441860?lang=zh_cn&edition=full","pubTime":"2024-12-11 02:22","pubTimestamp":1733854953,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日02时22分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅上涨5.05%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121102223395e8b948&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121102223395e8b948&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CVKD"],"gpt_icon":0},{"id":"2489555942","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489555942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489555942?lang=zh_cn&edition=full","pubTime":"2024-12-07 00:55","pubTimestamp":1733504157,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日00时55分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速跳水5.18%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207005557a1d9b473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207005557a1d9b473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","LENZ","BK4007"],"gpt_icon":0},{"id":"2489249274","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘股价大涨5.85%报13.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489249274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489249274?lang=zh_cn&edition=full","pubTime":"2024-12-06 03:46","pubTimestamp":1733428018,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日03时46分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速上涨5.85%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206034658971bee13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206034658971bee13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CVKD"],"gpt_icon":0},{"id":"2489143948","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘急速下挫5.42%报13.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489143948","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489143948?lang=zh_cn&edition=full","pubTime":"2024-12-05 02:25","pubTimestamp":1733336717,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日02时25分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下跌5.42%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205022517ab5d9b0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205022517ab5d9b0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CVKD"],"gpt_icon":0},{"id":"2488944086","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘快速跳水5.53%报14.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488944086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488944086?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:21","pubTimestamp":1733239306,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时21分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速下跌5.53%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203232146a269b03b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203232146a269b03b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","LENZ","BK4007"],"gpt_icon":0},{"id":"2487576562","title":"Cadrenal Therapeutics, Inc.盘中异动 临近午盘股价大涨6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487576562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487576562?lang=zh_cn&edition=full","pubTime":"2024-11-30 00:54","pubTimestamp":1732899253,"startTime":"0","endTime":"0","summary":"北京时间2024年11月30日00时54分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速拉升6.01%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130005413abe92931&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130005413abe92931&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CVKD"],"gpt_icon":0},{"id":"2486784378","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘大幅上涨5.25%报14.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486784378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486784378?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:30","pubTimestamp":1732717847,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时30分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速拉升5.25%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722304798e44e6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722304798e44e6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CVKD","BK4139","LENZ"],"gpt_icon":0},{"id":"2485545261","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485545261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485545261?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:36","pubTimestamp":1732286190,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时36分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速拉升5.73%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222363098e44290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222363098e44290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2484195977","title":"Cadrenal Therapeutics, Inc.盘中异动 急速跳水5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484195977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484195977?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:59","pubTimestamp":1732046369,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时59分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速下挫5.88%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.45%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120035929a2467fe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120035929a2467fe4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","CVKD","LENZ"],"gpt_icon":0},{"id":"2483589068","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘急速下跌5.85%报15.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483589068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483589068?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:19","pubTimestamp":1731698346,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日03时19分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速下跌5.85%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.87%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116031906abc56cd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116031906abc56cd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2483550038","title":"Cadrenal Therapeutics, Inc.盘中异动 快速跳水5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483550038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483550038?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:51","pubTimestamp":1731523889,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时51分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速跳水5.32%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114025129abbe605f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114025129abbe605f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CVKD"],"gpt_icon":0},{"id":"2482385317","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨6.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482385317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482385317?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:33","pubTimestamp":1731335622,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时33分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅上涨6.65%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122334298e41c68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122334298e41c68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2481610194","title":"Cadrenal Therapeutics, Inc.盘中异动 快速拉升5.84%报17.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481610194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481610194?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:40","pubTimestamp":1731076851,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时40分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速拉升5.84%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224051a224c89a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224051a224c89a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2481189360","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大涨5.59%报16.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481189360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481189360?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:31","pubTimestamp":1730989875,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时31分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅拉升5.59%。截至发稿，该股报16.80美元/股，成交量955股，换手率0.06%，振幅0.00%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107223115abaa7415&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107223115abaa7415&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CVKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cadrenal.com","stockEarnings":[{"period":"1week","weight":-0.0012},{"period":"1month","weight":0.1413},{"period":"3month","weight":0.1138},{"period":"6month","weight":1.2908},{"period":"1year","weight":0.512},{"period":"ytd","weight":0.4552}],"compareEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.0412},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.2518}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cadrenal Therapeutics, Inc.于2022年1月25日注册为特拉华州公司。该公司正在开发公司候选药物替卡法林，用于抗凝治疗方面未满足的需求。替卡法林是一种晚期新型口服和可逆抗凝血剂（血液稀释剂），用于预防心脏病发作、中风，以及需要慢性抗凝的罕见心血管疾病患者因血栓而死亡。","exchange":"NASDAQ","name":"Cadrenal Therapeutics, Inc.","nameEN":"Cadrenal Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cadrenal Therapeutics, Inc.,CVKD,Cadrenal Therapeutics, Inc.股票,Cadrenal Therapeutics, Inc.股票老虎,Cadrenal Therapeutics, Inc.股票老虎国际,Cadrenal Therapeutics, Inc.行情,Cadrenal Therapeutics, Inc.股票行情,Cadrenal Therapeutics, Inc.股价,Cadrenal Therapeutics, Inc.股市,Cadrenal Therapeutics, Inc.股票价格,Cadrenal Therapeutics, Inc.股票交易,Cadrenal Therapeutics, Inc.股票购买,Cadrenal Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}